Laser Photonics closed a public offering of 10,500,000 common shares at $0.75 per share, generating approximately $7.9 million in gross proceeds. The net proceeds are intended for research and development, acquisitions and working capital, while investors received two Warrant series exercisable upon issuance.
Key Highlights
- Series B-1 and Series B-2 warrants can be exercised upon issuance.
- H.C. Wainwright & Co. acted as the offering’s exclusive Placement agent.
- The offering generated approximately $7.9 million in gross proceeds before fees and other offering expenses.
Laser Photonics Corp (NASDAQ: LASE) raised approximately $7.9 million gross by selling 10,500,000 shares of common stock at $0.75 per share in a public offering that closed on September 14, 2026. Each share was accompanied by Series B-1 and Series B-2 warrants covering up to 10,500,000 common shares apiece, with a $0.75 per-share exercise price.
$7.9M Offering Includes Two Warrant Series
Both warrant classes were exercisable upon issuance. Series B-1 warrants and Series B-2 warrants each provide the right to purchase up to 10,500,000 common shares. H.C. Wainwright served as the exclusive placement agent for the transaction.
Net Proceeds Target R&D and Working Capital
The company develops laser systems for industrial and defense applications, including cleaning, surface preparation and precision material processing.
FAQs
Q: How much money did Laser Photonics raise in its public offering?
A: Laser Photonics generated approximately $7.9 million in gross proceeds from the offering. It sold 10,500,000 common shares at $0.75 per share before placement-agent fees and other offering expenses.
Q: What securities accompanied the Laser Photonics common stock?
A: Each common share was accompanied by Series B-1 and Series B-2 warrants. Each warrant series covered purchases of up to 10,500,000 common shares at a $0.75 exercise price.
Q: When did Laser Photonics close the public offering?
A: Laser Photonics closed the previously announced public offering on September 14, 2026. The offering included common shares and accompanying Series B-1 and Series B-2 warrants.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.